@misc{indiciae2b66790b1a09,
  title = {Chemoresistance of TP53 mutant AML requires the mevalonate byproduct, GGPP, for regulation of ROS and induction of a mitochondria stress response},
  author = {Skuli, S. J. and Bakayoko, A. and Kruidenier, M. and Manning, B. and Pammer, P. and Salimov, A. and Riley, O. and Brake-Silla, G. and Bowman, M. and Martinez-Gutierrez, L. N. and Buono, R. and Paul, M. and Saland, E. and Wong, S. and Xu, J. and Nee, E. and Hausler, R. and Anderson, C. and Reisz, J. A. and D'Alessandro, A. and Lai, C. and Maxwell, K. N. and Sarry, J.-E. and Fruman, D. A. and Mesaros, C. and Keith, B. and Simon, M. C. and Sung, P. J. and Wertheim, G. and Skuli, N. and Bowman, R. L. and Matthews, A. and Carroll, M.},
  year = {2024},
  doi = {10.1101/2024.06.07.597976},
  url = {https://www.biorxiv.org/content/10.1101/2024.06.07.597976v1},
  note = {Source identifier: 10.1101/2024.06.07.597976}
}